URINE ALBUMIN EXCRETION IN NON-DIABETIC MYOCARDIAL INFARCTION PATIENTS

Main Article Content

Deshpande Prasad
G. Devpura
Manna Bhattacharjee
Bijay Kumar
Vishvajit Wakade
Sheshkaran Singh Charan
Vishal Gaurab

Keywords

urine albumin excretion, non-diabetic patients, myocardial infarction

Abstract

Unfavorable prognosis associated with myocardial infarction shows emphasized the importance of evaluation of risk factors in patients with acute myocardial infarction; despite recorded treatment successes in the last decade. It is reported in population studies that an increased risk of cardiac morbidity is associated with Microalbuminuria. The objective of the study was to determine the association of urine albumin excretion rate values in non-diabetic Myocardial Infarction patients. This observational study was conducted in the Department of General Medicine and Cardiology at the National Institute of Medical Sciences and Research, Jaipur between 1st May 2023 to 28th February 2023. All non-diabetic Myocardial infarction patients of age more than 18 years were included after written consent.Among 50 patients, males were 40 (80%) and females were 10 (20%), and the mean age+/- S.D. was 64+/- 16.16. 84% had a smoking history. Prevalence of microalbuminuria was 60%. Findings revealed that there is a positive correlation between urine microalbumin and IHD and the changes in urine microalbumin can be better explained. Urine albumin excretion values had a strong association with myocardial infarction patients and in general it could be applied as a risk factor for cardiovascular diseases in non-diabetic patients.


 

Abstract 61 | PDF Downloads 46

References

1. Sonmez K, Eskisar AO, Demir D, Yazicioglu MV, Mutlu B. Increased urinary albumin excretion rates can be a marker of coexisting coronary artery disease in patients with peripheral arterial disease. Angiology 2006;57:15-20.
2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28(Suppl 1):S4- S36
3. Smith SC Jr. Reducing the global burden of ischemic heart disease and stroke: A challenge for the cardiovascular community and the United Nations. Circulation 2011;124:278 9.
4. Koenig W. Cardiovascular biomarkers: Added value with an integrated approach? Circulation 2007;116:3 5.
5. Garg JP, Bakris GL. Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med 2002;7:35 43.
6. American Diabetes Association. Standards of medical care in diabetes 2006. Diabetes Care 2006;29 Suppl 1:S4 42.
7. de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol 2006;17:2120 6.
8. Hashim R, Nisar S, Khalil ur Rehman, Naqi N. Microalbuminuria: Association with ischaemic heart disease in non diabetics. J Ayub Med Coll Abbottabad 2006;18:40 3
9. Awan ZA, Naveed AK, Malik MM, Khan S. Microalbuminuria in angiographically documented coronary heart disease in non diabetic and normotensive individuals. Ann King Edward Med Univ 2009;15:111 6.
10. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study. Circulation 2005;112:969 75